- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Next-Generation Biologics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Next-Generation Biologicsmarket, defines the market attractiveness level of Next-Generation Biologics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Next-Generation Biologics industry, describes the types of Next-Generation Biologics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Next-Generation Biologics market and the development prospects and opportunities of Next-Generation Biologics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Next-Generation Biologics market in Chapter 13.
By Player:
Molecular Partners
Sanofi
Roche
Pfizer
Novo Nordisk
Bayer
Allergan
Eli Lilly
Biogen Idec
Kyowa Hakko Kirin
By Type:
Antibodies
Regenerative medicine
Insulins
Growth hormones
Other
By End-User:
Medical
Scientific Research
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Next-Generation Biologics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Next-Generation Biologics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Next-Generation Biologics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Next-Generation Biologics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Next-Generation Biologics Market Analysis and Outlook to 2022
-
7.1 Global Next-Generation Biologics Consumption (2017-2022)
-
7.2 United States Next-Generation Biologics Consumption (2017-2022)
-
7.3 Europe Next-Generation Biologics Consumption (2017-2022)
-
7.4 China Next-Generation Biologics Consumption (2017-2022)
-
7.5 Japan Next-Generation Biologics Consumption (2017-2022)
-
7.6 India Next-Generation Biologics Consumption (2017-2022)
-
7.7 South Korea Next-Generation Biologics Consumption (2017-2022)
8 Region and Country-wise Next-Generation Biologics Market Analysis and Outlook to 2028
-
8.1 Global Next-Generation Biologics Consumption Forecast (2022-2028)
-
8.2 United States Next-Generation Biologics Consumption Forecast (2022-2028)
-
8.3 Europe Next-Generation Biologics Consumption Forecast (2022-2028)
-
8.4 China Next-Generation Biologics Consumption Forecast (2022-2028)
-
8.5 Japan Next-Generation Biologics Consumption Forecast (2022-2028)
-
8.6 India Next-Generation Biologics Consumption Forecast (2022-2028)
-
8.7 South Korea Next-Generation Biologics Consumption Forecast (2022-2028)
9 Global Next-Generation Biologics Market Outlook by Types and Applications to 2022
-
9.1 Global Next-Generation Biologics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Regenerative medicine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Insulins Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Growth hormones Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Next-Generation Biologics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Medical Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Scientific Research Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Next-Generation Biologics Market Outlook by Types and Applications to 2028
-
10.1 Global Next-Generation Biologics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Regenerative medicine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Insulins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Growth hormones Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Next-Generation Biologics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Medical Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Next-Generation Biologics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Next-Generation Biologics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Next-Generation Biologics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Next-Generation Biologics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Next-Generation Biologics Market Competitive Analysis
-
14.1 Molecular Partners
-
14.1.1 Molecular Partners Company Details
-
14.1.2 Molecular Partners Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Molecular Partners Next-Generation Biologics Product and Service
-
14.2 Sanofi
-
14.2.1 Sanofi Company Details
-
14.2.2 Sanofi Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi Next-Generation Biologics Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Next-Generation Biologics Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Next-Generation Biologics Product and Service
-
14.5 Novo Nordisk
-
14.5.1 Novo Nordisk Company Details
-
14.5.2 Novo Nordisk Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novo Nordisk Next-Generation Biologics Product and Service
-
14.6 Bayer
-
14.6.1 Bayer Company Details
-
14.6.2 Bayer Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer Next-Generation Biologics Product and Service
-
14.7 Allergan
-
14.7.1 Allergan Company Details
-
14.7.2 Allergan Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Allergan Next-Generation Biologics Product and Service
-
14.8 Eli Lilly
-
14.8.1 Eli Lilly Company Details
-
14.8.2 Eli Lilly Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly Next-Generation Biologics Product and Service
-
14.9 Biogen Idec
-
14.9.1 Biogen Idec Company Details
-
14.9.2 Biogen Idec Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Biogen Idec Next-Generation Biologics Product and Service
-
14.10 Kyowa Hakko Kirin
-
14.10.1 Kyowa Hakko Kirin Company Details
-
14.10.2 Kyowa Hakko Kirin Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Kyowa Hakko Kirin Next-Generation Biologics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Next-Generation Biologics
-
Figure Next-Generation Biologics Picture
-
Table Global Next-Generation Biologics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Next-Generation Biologics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Next-Generation Biologics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Next-Generation Biologics Consumption by Country (2017-2022)
-
Figure United States Next-Generation Biologics Consumption and Growth Rate (2017-2022)
-
Table Europe Next-Generation Biologics Consumption and Growth Rate (2017-2022)
-
Figure China Next-Generation Biologics Consumption and Growth Rate (2017-2022)
-
Figure Japan Next-Generation Biologics Consumption and Growth Rate (2017-2022)
-
Figure India Next-Generation Biologics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Next-Generation Biologics Consumption and Growth Rate (2017-2022)
-
Figure Global Next-Generation Biologics Consumption Forecast by Country (2022-2028)
-
Figure United States Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Regenerative medicine Consumption and Growth Rate (2017-2022)
-
Figure Global Insulins Consumption and Growth Rate (2017-2022)
-
Figure Global Growth hormones Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Consumption and Growth Rate (2017-2022)
-
Figure Global Scientific Research Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Regenerative medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Growth hormones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Next-Generation Biologics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Next-Generation Biologics Export by Region (Top 5 Countries) (2017-2028)
-
Table Molecular Partners (Foundation Year, Company Profile and etc.)
-
Table Molecular Partners Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Molecular Partners Next-Generation Biologics Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Next-Generation Biologics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Next-Generation Biologics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Next-Generation Biologics Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Next-Generation Biologics Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Next-Generation Biologics Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Next-Generation Biologics Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Next-Generation Biologics Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Next-Generation Biologics Product and Service
-
Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)
-
Table Kyowa Hakko Kirin Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa Hakko Kirin Next-Generation Biologics Product and Service
-